Updated Oct 28, 2026 · 10:56 UTC
ABTAbbott Laboratories
Health Care · United States · XNYS · pharmaceutical preparations
$102.78−1.70%last session · market early-hours
Market cap
$177.84b
real-world
Tokenized
$1.5m
<0.001% of the asset
Avg token price
$102.40
−0.36% vs real
Spot volume, 24h
$556k
7 venues
Derivatives, 24h
—
Perp open interest
—
In DeFi
—
ABT · Price
Token Real
EarningsNasdaq’s earnings calendar
Last earnings, Oct 21
$1.42 EPS
−0.7% vs $1.43 forecast · Sep 2026 quarter
Real marketAbbott Laboratories
Last close
$103.10
Oct 27
Traded on Oct 27
$670.7m
Price now
$102.78
market early-hours
Where it trades24h volume by venue, as the exchanges report it · open interest and funding on the perpetuals
Spot · $556k · 7 venues
Gate2 pairs$190k
Ourbit1 pair$129k
Hibt1 pair$120kDerivatives · — · 0 venues
None yet
In DeFiPools and lending markets that hold these tokens
None found
Onchain versions3 tokens from 2 issuers
ABTonOndo Assets$102.21$1.4m
ABTXBacked Assets$103.47$157k
WABTXBacked Assets——HoldersAddresses holding its tokens on each chain counted, each token counted and added, issuers’ own addresses left out · the value is what they hold onchain
Solana279 holders$144k
Ethereum260 holders$1.4m
BNB Chain140 holders$4k
Ink9 holders$5k
TON9 holders$6k
Arbitrum— holders$0Business 12 months to Mar 2026 · SEC EDGAR
Results
Revenue
$45.13b
+7% YoY
Operating income
$7.71b
17% margin · +8% YoY
Net income
$6.28b
14% margin · −54% YoY
EPS, diluted
$3.59
−54% YoY
Diluted shares
1.75b
−0% YoY
Cash and balance sheet
Free cash flow
$7.38b
16% of revenue · 4.1% yield
Net debt
$26.75b
$7.29b cash and securities, $34.05b debt
Quarterly
RevenueNet income
Valuation today’s market cap $177.84b · enterprise value $204.59b
P/E
28.3×
EV / sales
4.5×
EV / op. income
26.6×